This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent. Top assignees: Alfa Wassermann, Inc., Alfasigma S.p.a.. Active years: 1998-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2019
Title: The Innovative Mind of Villiam Zamboni
Introduction: Villiam Zamboni, an accomplished inventor based in Bologna, Italy, has made significant contributions to the field of pharmaceuticals. With three patents to his name, Zamboni is particularly noted for his work on gastroresistant pharmaceutical formulations that enhance the efficacy of rifaximin, a medication used to treat inflammatory bowel diseases.
Latest Patents: Zamboni's most recent patents focus on gastroresistant pharmaceutical formulations containing rifaximin. These innovative formulations comprise microgranules designed to be gastroresistant through an insoluble polymer, functioning effectively at pH values between 1.5 and 4.0, while remaining soluble at pH levels ranging from 5.0 to 7.5. These advancements are chiefly valuable in the development of medicinal preparations aimed at treating inflammatory bowel diseases, particularly Crohn's disease.
Career Highlights: Throughout his career, Zamboni has collaborated with renowned companies in the pharmaceutical sector, including Alfa Wassermann S.p.a. and Alfasigma S.p.a. His work has carved a niche in the medical field, blending innovative science with practical application to enhance patient care.
Collaborations: Zamboni's professional journey has been enriched by his collaborations with colleagues such as Giuseppe Claudio Viscomi and Ernesto Palazzini. These partnerships have fostered an environment of creativity and collective problem-solving, essential for the continued advancement in pharmaceutical innovations.
Conclusion: Villiam Zamboni stands out not just for his technical skills as an inventor, but also for his dedication to improving therapeutic options for patients with inflammatory bowel diseases. His insights into gastroresistant pharmaceutical formulations represent a notable advancement in medicine, validating the importance of innovation in tackling complex health challenges. Through his patents, Zamboni continues to pave the way for future breakthroughs in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile